Getting bad news from the Food and Drug Administration is never a good thing But neglecting to inform the market immediately just makes the problem worse Danish drug maker Novo Nordisk on Monday said it would pay a  Danish kroner  fine imposed by Denmarks public prosecutor for failing to immediately tell investors about a rejection letter from the FDA concerning two of the companys insulin products